Home › Astrocytoma › Alabama › Birmingham
Astrocytoma clinical trials in Birmingham, AL
3 studies for Astrocytoma are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RecruitingPhase 1
- University of Alabama at Birmingham Cancer Center, Birmingham
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- University of Alabama, Birmingham
Study of Pembrolizumab and M032 (NSC 733972)
RecruitingPhase 1/2
- University of Alabama at Birmingham, Birmingham
Astrocytoma trials in other cities
- Houston, TX14 studies
- Boston, MA13 studies
- Chicago, IL9 studies
- New York City, NY9 studies
- Philadelphia, PA7 studies
- Miami, FL7 studies
- Washington, DC6 studies
- Durham, NC6 studies
- Seattle, WA6 studies
- Columbus, OH6 studies
- San Francisco, CA6 studies
- Aurora, CO5 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Breast Cancer24 studies
- Obesity23 studies
- Ovarian Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- COPD17 studies
- Cardiovascular Disease17 studies
- Overweight16 studies
- Endometrial Cancer16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.